Key result
myh6 knockout in zebrafish reduces atrial fractional shortening by ~59% and disrupts sarcomere structure.
Why the study?
The role of MYH6 in atrial diseases has not been fully elucidated, and the genetic causes of atrial cardiomyopathy require further investigation.
Absolute Event Rate: 0.14% vs 0.34%
p-value: p=<0.0001
MYH6 defects impair atrial and ventricular function and disrupt sarcomere organization, highlighting the role of sarcomeric abnormalities in atrial remodeling and atrial fibrillation.
No immediate clinical implications; leaves open MYH6 relevance to human atrial cardiomyopathy.
Atrial cardiomyopathy, which often comes with underlying genetic defects, has been recognized as a possible substrate of atrial fibrillation. MYH6 encodes α-myosin heavy chain (α-MHC), predominantly expressed in the atria and pivotal in sarcomere organization and muscle contraction. Genetic investigation in patients with a family history of atrial cardiomyopathy identified three probands carrying MYH6 variants (D629N, V893M, A1327T). However, the role of MYH6 in atrial diseases has not been fully elucidated, and the genetic cause of atrial cardiomyopathy needs further investigation. Here, we employed CRISPR/Cas9 to generate myh6 knockout zebrafish, assessing cardiac abnormalities in structural, electrical, and gene expression levels through diverse methodologies. Our findings revealed that myh6 defects in zebrafish impaired atrial and ventricular function and disordered sarcomere, which underscores the pivotal role of MYH6 in maintaining atrial function and development. Transcriptomic sequencing also identified 1318 differentially expressed genes enriched in muscle development, calcium ion homeostasis, and sarcomere pathways. The association between MYH6 dysfunction and atrial cardiomyopathy highlights the role of sarcomeric abnormalities in atrial remodeling, a process implicated in atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied Atrial cardiomyopathy and atrial fibrillation. myh6 knockout / MYH6 variants vs. Wild-type (WT) zebrafish / non-carriers was evaluated on Atrial fractional shortening (A-FS) in 72-hour zebrafish larvae (p=<0.0001). myh6 knockout in zebrafish resulted in significantly impaired atrial fractional shortening (0.14% in homozygous mutants vs 0.34% in wild-type, p<0.0001) and disordered sarcomere structure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: